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Aspects of Mercury(II) Thiolate Chemistry and the 
Biological Behavior of Mercury Compounds 
ALLAN J. CANTY 
Chemistry Department, University of Tasmania, Hobart, Tasmania, Australia 
Complex formation between mercury compounds and thiols, e.g. 
cysteine, is believed to playa major role in the biological 
chemistry of mercury(}). The greater affinity of H9(II) and 
MeHg(II) for thiols than other possible biological donor ligands 
has been well documented by stability constant studies in 
aqueous solution (~,~.  Our interest in mercury(II) thiolates 
stems from studies of the chemistry of the antidote British 
anti-Lewisite which indicated that the structure and reactivity 
of simple thiolate complexes was little understood. In this 
review our recent work on the interaction of inorganic and 
organomercury compounds with British anti-Lewisite, simple
thiols and sulphur containing amino acids is discussed, followed 
by an account of animal studies of the distribution and 
metabolism of phenylmercury compounds. In discussing the 
implications of chemical results, e.g. reactivity of thiolates, 
for the biological behaviour of mercury compounds it is assumed 
here that chemical studies provide only plausible pathways for 
biological behaviour. 
In recent years other workers have reported studies of 
mercury thiolates that are related to the work described here, 
in particular nuclear magnetic resonance studies of the 
interaction of MeHg(II) with thiols (4-9) and the preparation 
(10-16) and X-ray structural analysis-of key complexes of 
H9(IT), MeHg(II), and PhHg(II) with sulphur containing amino 
acids (lQ-l10. 
Complexes of British anti-Lewisite and other Thiols 
British anti-Lewisite [dimercaprol, 2,3-dimercaptopropanol; 
abbreviated BALH3 to indicate loss of thiol protons on complex
formation, e.g. Hg(BALH)] has been used for the treatment of 
mercury poisoning in humans (17,l]0 and has been studied 
extensively in animal experimentsr~-~. Although it may be 
eventually replaced by a more satisfactory treatment, e.g.
hemodialysis (25,m, it is successful for poisoning by 
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inorganic mercury (IL,!§) and is the most satisfactory 
antidote for phenylmercury(II) poisoning [animal experiments 
only to date (18)], but has no therapeutic effect for 
methylmercury(IT) poisoning in humans or animals (18). For 
PhHg(II) poisoning BALH3 greatly increases the amount of 
mercury in the brain compared with the bodily distribution in 
the absence of BALH3 treatment (~,~,20,~,  and for MeHg(II) 
it merely hastens the distribution of mercury and may increase 
the amount of mercury in the brain (18). An increased mercury 
content in the brain is undesirable,ias it attacks the central 
nervous system. BALH3 also increases the amount of mercury in 
the brain following its administration for inorganic mercury 
poisoning (~,23,~,  but this effect has been explained in 
terms of the timing and dosage of BALH3 (24).
Isolation of Hg(BALH) (27,28) and evidence for the 
formation of [H9(BALH)2]2- (27)~(PhHg)2BALH (28). and 
(RHg)nBALH3_n[n = 1 (~),  2 128); R = CH2CH(OMerCH2R~]  were 
reported by several workers soon after the introduction of 
BALH3 as an antidote for heavy metal poisoning. Mercuric 
chloride reacts immediately with BALH3 in water to form a white 
sol id identified as Hg(BALH) (27,28,30,llJ. 
H9C1 2 + BALH3 + Hg(BALH) + 2HCl 
Crystal structures of simple thiolates Hg(SR)2 reveal 
either linear monOmers [R=Me (32), Et (33)] (Figure 1) or a 
polymeric structure with tetrahedral mercury (R=Bu t) (34)
(Figure 2). Infrared and Raman spectra indicate that highly 
insoluble Hg(BALH) has a polymeric structure based on linear 
coordination for mercury (31) (Figure 3), rather than the 
cyclic structure usually presented (Figure 4). Thus, Hg(BALH) 
has va~(SHgS)  348 and vs(SHgS) 298 cm-l, similar to that of 
Hg(SMeJ2 (377 and 297 cm- l) and well removed from tetrahedral 
mercury in Hg(SBut)2 (172 and 188 cm-l) (31). Spectroscopic
properties appropriate for identification of Hg(II) thiolates,  
e.g. infrared, Raman, and nuclear magnetic resonance, are 
presented elsewhere (31,35,36,37,38,39).
The simple thiolateS-Hg[SR}2ilre-insoluble in water but 
soluble in organic solvents, e.g. Hg(SR)2 (R=Et,But,Ph) are 
monomeric in chloroform. Hg(BALH) is insoluble in water, even 
at concentrations of ca. lO-4M (~. An impure form of 
Hg(BALH) can be isolated by reaction of mercuric acetate with 
BALH3 in pyridine (35). This solid is soluble in pyridine, and 
the related complex of 1,3-dimercaptopropanol, Hg(DMPH), can be 
isolated from water and forms a dimer in pyridine (~).  The 
structure of Hg(DMPH) in pyridine is unknown but presumably 
involves pyridine ~oordination,  [Hg(DMPH)pYx]2' as it crystall-
izes as Hg(DMPH)pYl.5 containing coordinated pyridine. The 
solubility of impure Hg(BALH) in pyridine is of interest as 
Hg(BALH) is presumably formed in many "environments" In vivo, 
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and pyridine solubility suggests higher solubility in lipid
tissue than more aqueous regions. The neutral complex may
be present as a dimer [Hg(BALH)L~]2 related to Hg(DMPH) in 
pyridine, or possibly as the cyclic complex (Figure 4) with 
additional ligands coordinated to mercury. 
In alkaline solution Hg(BALH) dissolves on addition of 
excess BALH3 suggesting (27) formation of [Hg(BALH)2]2-, and 
addition of 8ALH3 to a solution of impure Hg(8ALH) in pyridine 
results in an increase in conductivity (~.  Stability 
constants for formation of the neutral and ionic complexes in 
water have recently been determined by potentiometric titration 
(~.  and the very high values contribute to the effectiveness 
of British anti-Lewisite as an antidote. 
Hg2+ + BALH2- ~ Hg(BALH) Log K = 25.74 ± 0.45 
Hg(BALH) + BALH2- ~ [H9(BALH)2]2- Log K = 8.61 ± 0.10 
Organomercury derivatives of BALH3 may be obtained by 
r~action with phenylmercuric acetate in water and methy1- . 
.ercuric acetate in benzene (35). 
2RH902CMe + BALH3 ~ (RHg)2BALH + 2MeC0 2H 
Infrared and Raman spectra of these complexes and other 
organomercury thiolates indicate monomeric structures in the 
solid state as v(Hg-S) values (326-388 cm-1) are in the region 
expected for linear coordination for mercury, and coincidence 
of infrared and Raman values indicate absence of a centre of 
symmetry at mercury (Figure 5.6) (~,  thus excluding dimeric 
structures similar to that formed by related PhHg(II) a1koxides 
in benzene (Figure 7) (!lJ.
lH NMR spectroscopy is particularly useful for character­
ization of organomercury compounds. Thus. (MeHg)28ALH has 
J(lH-199Hg) 169 Hz for the MeHg(II) group. and PhHg(II) thio1ates 
have J(orthoH-199Hg) 144-158 Hz and J(orthoH-metaH) 6-8 Hz 
(w· . 
The complexes (RHg)2BALH (R=Me.Ph) are insoluble in water 
but dissolve 1n pyridine and dimethylsulphoxide, and the 
related thio1ate of lower molecular weight. PhHgSCH2CH20H. is 
soluble and monomeric in chloroform. However. organomercury
thio1ates formed from naturally occurring thio1s in vivo are 
likely to be water soluble. e.g. the L-cysteine complexes 
MeHgSCH2CH(NH3)C02·H20 and PhHgSCH2CH(NH3)C02 contain hydro­
philic zwitterionic groups and crystallize from aqueous ethanol 
(l£.~.  Thus. displacement of biological thio1 ligands with 
BALH3 is expected to form more lipid soluble complexes, as 
suggested by Berlin et!l. (fQJ, and may account for higher
concentrations of mercury in brain tissue of animals administered 
BALH3 after injection of organomercury compounds when compared 
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with concentrations in the absence of BALH3 treatment. 
It was found that (PhHg)2BALH decomposes at ambient 
temperature in acetone, benzene, and methanol to form Ph2H9 
(30.35) (Table I). 
(PhH9)2BALH~  + Hg(BALH)Ph 2Hg 
Table I 
Decomposition of Some Phenyl mercury (II) Thiolatesa 
Complex Solvent Yield of Ph 2Hg(%) 
(PhHg)2BALH acetone 96 
(PhHg)2BALH benzene 100 'IPhHg(H3cyst) benzene 55 
.,PhHg(113pen) benzene 81 
(PhHg)2(H2cyst)·H20 benzene 44 
(PhHg)2H2pen benzene 43 
aFrom reference~; 35.36. Suspensions at ambient temperature 
were stirred magnetically for seven days. Ph2H9 was isolated 
as a pure solid from the filtrate.  
bYield of Ph2Hg based on 'Phi.  
CH3cyst = SCH2CH(NH3)C02; H2cyst = SCH2CH(NH2)C02; similarly for 
HSCMe2CH(NH3)C02. DL-penicillamine. 
If this reaction occurs in vivo it may also contribute to 
redistribution of mercur~  and to indicate whether Ph2Hg 
formation may be a general biological reaction in the absence 
of BALH3 a series of PhHg(II) complexes of sulphur-containing 
amino acids was prepared and their stabilities studied (36). 
The complexes were synthesized by reaction of phenylmercuric 
acetate with the amino acids in aqueous ethanol, e.g.  
2PhHg02CMe + H4cyst ~ (PhHg)2(H2cyst)'H20 + 2MeC02H 
The DL-penicillamine complexes have been prepared by other 
workers. but the stability of the complexes toward decomposition 
had not been studied (16). 
The amino acid complexes were found to decompose in benzene 
to form Ph2H9 (Table I). The importance of these reactions. 
and decomposition of (PhHg)2BALH. is difficult to assess as they 
are solvent dependent and rates of decomposition vary. e.g. 
(PhHg)2BALH and amino acid complexes may be readily prepared in 
r~ 
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, I 
aqueous solution, they decompose slowly in benzene, and when 
PhHg02CMe and BALH3 are reacted in ethanol immediate pre­
cipitation occurs and Ph2Hg may be obtained from the filtrate 
on filtration. If Ph2H9 is formed ~ vivo then the biological 
behaviour of Ph2H9 is of interest as phenyl mercury compounds, 
e.g. PhHg02CMe, are still widely used in agriculture and 
medicine. It has been reported that Ph2H9 in "scarcely detectable" concentration formed by degradation of phenyl­
mercuric acetate (formerly contained in derelict steel drums), 
was sufficiently toxic to kill fish within a few hours in the 
Boone Reservoir, Tennessee Valley (~. 
Biological Behaviour of Diphenylmercury 
Diphenylmercury has quite different physical and chemical 
properties than PhHg(ll) compounds, e.g. it is a neutral non­
polar molecule insoluble in water but soluble in organic 
solvents and is thus expected to be lipid soluble (44). and in 
contrast to PhHg(ll) compounds (45,46,47) it interacts only 
weakly with donor molecules (48,49,~:- Similarly, Me2H9 
does not form complexes (1§) but MeHg(ll) forms stable complexes. 
e.g. [MeHgL]+ with pyridine (51,~,  2,2'-bipyridyl ([L,52,53, 
~,  and 1,10-phenanthroline 11)2,53). 
In distribution and metabolism studies we have injected 
ethanol solutions of mercuric chloride, phenylmercuric acetate, 
or Ph2H9 intraperitoneally into rats (55,~.  The rats were 'I 
sacrificed at intervals ranging from 20 min. to 7 days and : 
samples of blood, brain, liver, kidney, muscle, fat, and spleen 
were analysed for mercury. In another series of experiments 
faecal and urinary excretion was monitored for several days 
after injection. 
During the first few days after injection, urinary excretion 
of mercury was much higher for the diphenylmercury-injected 
rats than for the phenylmercuric acetate or mercuric chloride­
injected rats, with mercuric chloride having the lowest rate of 
excretion. Faecal excretion was similar for the three comp­
ounds, with phenylmercuric acetate being more rapidly excreted 
(Table II).
Analyses of blood and tissues for total mercury indicated 
that after initial marked differences in brain and fatty tissue 
concentrations, the distribution of mercury for Ph2H9 resembled 
those of the other compounds after 1 day, but concentrations 
were generally lower than for the other compounds (55,56). The 
lower concentrations are explained by the more rapid excretion of 
mercury from Ph2H9. -4 
During the first hour after injection mercury from 
Ph2H9 ac~ulated at a higher concentration in the brain than 
from the other compounds, but after 6 hours these concentrations 
had decreased considerably (55,56). The concentration of mercury 
in fatty tissue was 10-20 timeslhigher for diphenylmercury­
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Table II 
Urinary and Faecal Excretionaof Mercury from Rats within 
Two Days of Injection 
HgC1 2 PhHg02CMe Ph 2Hg 
Percentage of dose excreted 
Urinary Excretion: 2.5 2.2 4.8 8.0 30.5 38.3 
Faecal Excretion: 5.2 4.5 12.2 8.4 5.6 3.6 
Urinary + Faecal: 7.7 6.7 17.0 16.4 36.1 41.9 
aFrom reference 56. Analyses for total mercury, as described 
elsewhere (~'  -rwo rats were injected intraperitoneally with 
each compound, dose 248 mg mercury, all rats of weight 160 g. 
injected rats at 20 min. after injection, but then rapidly 
dropped to values similar to the other mercury compounds (Table
III). The much higher concentration of mercury in brain and 
fatty tissue immediately after Ph2Hg injection is consistent 
with distribution of mercury ~ and this was confirmedPh2H9.by thin-layer chromatography. A sample of fatty tissue taken 
from a diphenylmercury-injected rat 20 min. after injection was 
blended with benzene using a small Waring blender. and thin-
layer chromatography showed the presence of diphenylmercury 
(ultraviolet irradiation); the silica gel of the plate at 
the Rf value of Ph2Hg contained 5.19 mg. of Hg/g of silica 
gel compared with 0.15 mg/g for silica gel at lower Rf value 
on the same plate.
It has been established that phenylmercury is degraded to 
inorganic mercury in a few days in rats (57.58,59,60,[L). Daniel 
et ~.  (§Q) represent this breakdown as 
+ + 2+
+ H ~  CC6H5H9 6H6 + Hg 
A similar breakdown may occur for Ph2Hg, presumably via PhHg(II), 
as the initial high concentrations of mercury in brain and 
fatty tissue fall to values similar to that obtained with the 
other compounds after 6 hr. and 1 hr., respectively. Thus. 
is formed in vivo its biological effects are difficultif Ph2Hgto evaluate as it is more rapidly excreted than PhHg(II) and 
apparently broken down by the body, but has a quite different 
initial distribution. However, it is of interest to note that 
although mercury vapour is oxidized to Hg(II) in ca. 30 sec. in 
blood this is sufficient time for mercury (from vapour) to 
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Table III 
Concentration of Mercury in Brain and Fatty Tissues of HoodedaWistar Rats Injected Intraperitoneally with Mercury Compounds 
Time Brain Fat 
A. Dose of 6 mg. of Hg/kg of rat. 
mercuric chloride 
20 min. (2) 
1 hr. (2) 
6 hr. (2) 
1 day (2) 
20 min. (2) 
1 hr. (2) 
6 hr. (2) 
1 day (2) 
20 min. (2) 
1 hr. (2) 
6 hr. (2) 
1 day (2) 
0.16 ± 0.02 
0.33 ± 0.07 
0.16 ± 0.01 
0.24 
phenylmercuric acetate 
0.14 ± 0.04'" 
0.47 ± 0.03 
0.9 ± 0.3 
0.65 ± 0.02 
diphenylmercury 
0.9 ± 0.2 
0.7 ± 0.2 
0.26 ± 0.01 
0.20 ± 0.03 
10.5 ± 2.8 
4.8 ± 2.1 
3.4 ± 1.3 
15.7 ± 5 
5 ± 2 
4.4 ± 1.2 
4.7 ± 0.2 
3.5 ± 0.3 
147 ±13 
10.4 ± 3.2 
10.1 ± 3.4 
3.6 ± 0.2 
B. Dose of 1.5 mg. of Hg/kg of rat. 
mercuric chloride 
20 min. (1) 
20 min. (1) 
20 min. (1) 
0.04 
phenylmercuric acetate
0.01 
diphenylmercury
0.3 
2.34 
0.9 
27.8 
aFrom reference 56. Recorded as ~g  of Hg/g tissue, wet weight. 
and the range of-Values is indicated. The number of rats in each 
category is given in parentheses with the time. 
achieve an ca. ten-fold higher accumulation in the brain than 
from inorganic mercury poisoning (27,§fj leading to higher
toxicity of mercury vapour. 
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